Tower Research Capital (TRC)’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$286K	Sell	12,153 -2,731	-18%	-$69.7K	0.01%	1336
2025 Q4	$432K	Buy	14,884 +10,148	+214%	+$260K	0.01%	909
2025 Q3	$89.3K	Sell	4,736 -7,678	-62%	-$121K	﹤0.01%	2089
2025 Q2	$174K	Buy	12,414 +9,135	+279%	+$128K	﹤0.01%	1916
2025 Q1	$51.3K	Sell	3,279 -10,952	-77%	-$154K	﹤0.01%	2214
2024 Q4	$198K	Buy	14,231 +5,488	+63%	+$60.1K	﹤0.01%	1728
2024 Q3	$81.3K	Sell	8,743 -10,177	-54%	-$100K	﹤0.01%	2385
2024 Q2	$176K	Buy	18,920 +16,532	+692%	+$150K	﹤0.01%	2176
2024 Q1	$23.7K	Sell	2,388 -2,031	-46%	-$15.2K	﹤0.01%	2846
2023 Q4	$14.3K	Buy	4,419 +556	+14%	+$1.51K	﹤0.01%	3898
2023 Q3	$20.5K	Sell	3,863 -8,128	-68%	-$69.1K	﹤0.01%	3348
2023 Q2	$114K	Buy	11,991 +9,367	+357%	+$104K	﹤0.01%	1940
2023 Q1	$29K	Sell	2,624 -6,241	-70%	-$90.3K	﹤0.01%	3015
2022 Q4	$131K	Buy	8,865 +6,035	+213%	+$105K	0.01%	1610
2022 Q3	$54K	Sell	2,830 -9,047	-76%	-$205K	﹤0.01%	3091
2022 Q2	$253K	Buy	11,877 +11,018	+1,283%	+$226K	0.01%	1608
2022 Q1	$16K	Sell	859 -940	-52%	-$15.9K	﹤0.01%	3741
2021 Q4	$38K	Buy	1,799 +803	+81%	+$16K	﹤0.01%	2994
2021 Q3	$23K	Sell	996 -1,860	-65%	-$42.4K	﹤0.01%	3583
2021 Q2	$78K	Buy	2,856 +1,627	+132%	+$45.8K	﹤0.01%	2625
2021 Q1	$36K	Buy	1,229 +849	+223%	+$26.5K	﹤0.01%	3390
2020 Q4	$11K	Sell	380 -10,960	-97%	-$268K	﹤0.01%	4243
2020 Q3	$332K	Buy	11,340 +9,756	+616%	+$261K	﹤0.01%	2089
2020 Q2	$48K	Buy	1,584 +322	+26%	+$9.31K	﹤0.01%	3073
2020 Q1	$38K	Buy	+1,262	New	+$33.9K	﹤0.01%	1409